Fixed drug eruption due to cotrimoxazole

Area of Science:

• Dermatology
• Pharmacology
• Cutaneous Medicine

Background:

• Drug eruptions are frequent dermatologic conditions.
• Fixed Drug Eruption (FDE) presents uniquely and can be triggered by various medications.
• The prevalence of FDE varies globally, influenced by drug usage patterns.

Purpose of the Study:

• To analyze the characteristics of Fixed Drug Eruption (FDE).
• To investigate the association between FDE and specific causative agents.
• To report recent trends in FDE cases, particularly those linked to Cotrimoxazole.

Main Methods:

• Review of clinical cases presenting with drug eruptions.
• Identification of patients with Fixed Drug Eruption (FDE).
• Analysis of causative agents, focusing on Cotrimoxazole.

Main Results:

• Drug eruptions manifest in diverse forms, often resembling other skin conditions.
• Fixed Drug Eruption (FDE) is a distinct entity with characteristic clinical features.
• A notable increase in FDE cases attributed to Cotrimoxazole has been observed recently.

Conclusions:

• Fixed Drug Eruption (FDE) requires careful diagnosis due to its varied presentation.
• Cotrimoxazole is identified as a significant agent inducing FDE.
• Awareness of drug-specific FDE patterns is crucial for dermatologists.